TCM
IBB icon

Telos Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Telos Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
8,609
-689
-7% -$118K 0.14% 108
2026
Q1 		$1.57M Sell
9,298
-531
-5% -$90.8K 0.15% 105
2025
Q4 		$1.66M Sell
9,829
-972
-9% -$158K 0.15% 104
2025
Q3 		$1.56M Sell
10,801
-535
-5% -$73K 0.15% 100
2025
Q2 		$1.43M Buy
11,336
+436
+4% +$53.5K 0.15% 106
2025
Q1 		$1.39M Sell
10,900
-99
-0.9% -$13.4K 0.15% 104
2024
Q4 		$1.45M Buy
10,999
+209
+2% +$29.4K 0.16% 104
2024
Q3 		$1.57M Sell
10,790
-349
-3% -$50.5K 0.16% 101
2024
Q2 		$1.53M Buy
11,139
+177
+2% +$23.6K 0.17% 95
2024
Q1 		$1.5M Sell
10,962
-33
-0.3% -$4.51K 0.17% 96
2023
Q4 		$1.49M Buy
10,995
+73
+0.7% +$8.91K 0.18% 94
2023
Q3 		$1.34M Buy
10,922
+349
+3% +$44.4K 0.19% 97
2023
Q2 		$1.34M Buy
10,573
+329
+3% +$42.7K 0.18% 97
2023
Q1 		$1.32M Sell
10,244
-203
-2% -$26.6K 0.18% 95
2022
Q4 		$1.37M Buy
10,447
+1,098
+12% +$142K 0.2% 96
2022
Q3 		$1.09M Buy
9,349
+29
+0.3% +$3.6K 0.18% 99
2022
Q2 		$1.1M Buy
9,320
+314
+3% +$37.3K 0.17% 101
2022
Q1 		$1.17M Buy
9,006
+802
+10% +$104K 0.15% 106
2021
Q4 		$1.25M Sell
8,204
-14,193
-63% -$2.2M 0.16% 102
2021
Q3 		$3.62M Sell
22,397
-37
-0.2% -$6.23K 0.5% 70
2021
Q2 		$3.67M Buy
22,434
+873
+4% +$134K 0.49% 71
2021
Q1 		$3.25M Sell
21,561
-40
-0.2% -$6.35K 0.47% 75
2020
Q4 		$3.27M Sell
21,601
-1,366
-6% -$195K 0.5% 69
2020
Q3 		$3.11M Sell
22,967
-284
-1% -$38.5K 0.54% 66
2020
Q2 		$3.18M Sell
23,251
-993
-4% -$127K 0.62% 61
2020
Q1 		$2.61M Buy
24,244
+1,360
+6% +$157K 0.65% 55
2019
Q4 		$2.76M Buy
22,884
+638
+3% +$71.2K 0.63% 62
2019
Q3 		$2.21M Buy
22,246
+301
+1% +$31.5K 0.61% 63
2019
Q2 		$2.4M Buy
21,945
+816
+4% +$86.8K 0.7% 54
2019
Q1 		$2.36M Sell
21,129
-277
-1% -$30.4K 0.74% 55
2018
Q4 		$2.06M Buy
21,406
+976
+5% +$104K 0.76% 53
2018
Q3 		$2.49M Buy
20,430
+323
+2% +$38K 0.8% 51
2018
Q2 		$2.21M Sell
20,107
-28,701
-59% -$3.07M 0.76% 54
2018
Q1 		$5.21M Buy
48,808
+1,401
+3% +$155K 1.85% 8
2017
Q4 		$5.06M Buy
47,407
+2,863
+6% +$306K 1.79% 10
2017
Q3 		$4.95M Buy
44,544
+11,142
+33% +$1.19M 1.91% 6
2017
Q2 		$3.45M Buy
33,402
+1,608
+5% +$158K 1.38% 16
2017
Q1 		$3.11M Buy
31,794
+1,530
+5% +$146K 1.29% 21
2016
Q4 		$2.68M Buy
30,264
+24,936
+468% +$2.27M 1.19% 27
2016
Q3 		$514K Buy
5,328
+120
+2% +$11.4K 0.24% 99
2016
Q2 		$447K Buy
5,208
+954
+22% +$85.6K 0.22% 105
2016
Q1 		$370K Buy
4,254
+1,605
+61% +$144K 0.19% 109
2015
Q4 		$299K Sell
2,649
-210
-7% -$22.8K 0.16% 124
2015
Q3 		$289K Buy
2,859
+156
+6% +$18.7K 0.18% 116
2015
Q2 		$332K Buy
2,703
+234
+9% +$28K 0.18% 118
2015
Q1 		$283K Buy
2,469
+27
+1% +$2.98K 0.17% 119
2014
Q4 		$247K Sell
2,442
-5,634
-70% -$548K 0.15% 128
2014
Q3 		$737K Sell
8,076
-450
-5% -$39.5K 0.46% 81
2014
Q2 		$731K Sell
8,526
-189
-2% -$14.9K 0.45% 84
2014
Q1 		$687K Sell
8,715
-825
-9% -$68.7K 0.48% 80
2013
Q4 		$722K Sell
9,540
-120
-1% -$8.51K 0.53% 78
2013
Q3 		$675K Sell
9,660
-222
-2% -$14.5K 0.55% 74
2013
Q2 		$573K Buy
+9,882
New +$571K 0.5% 78

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Telos Capital Management's IBB Position: Q2 2026 in Review

Telos Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 7.4% in Q2 2026, selling an estimated $118K and leaving 8,609 shares worth $1.64M. The position accounts for 0.14% of the portfolio, ranked #108.

Telos Capital Management first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.21M in Q1 2018. 294 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Telos Capital Management held 8,609 shares of iShares Biotechnology ETF worth $1.64M as of Q2 2026.
  • Telos Capital Management sold 689 iShares Biotechnology ETF shares in Q2 2026, an estimated $118K.
  • iShares Biotechnology ETF made up 0.14% of Telos Capital Management's portfolio in Q2 2026, its #108 holding.
  • Telos Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Telos Capital Management's iShares Biotechnology ETF position peaked at $5.21M in Q1 2018.
  • 294 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.